Immunitybio, Inc. · NASDAQ:IBRX
Selecky Christobel sold 159,478 Immunitybio, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 6, 2026
On Jul 1, 2026, Selecky Christobel (Director) sold 159,478 Immunitybio, Inc. shares at US$9.02 for US$1.44M under a trading plan, leaving 0 shares. Filed Jul 6, 2026 (Form 4).
- Sold
- 159,478 shares
- Price
- US$9.02
- Value
- US$1.44M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Option exercise | 35,064 | US$2.98 | 35,064 | Direct |
| Jul 1, 2026 | Common Stock | Option exercise | 124,414 | US$2.99 | 159,478 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 159,478 | US$9.02 | 0 | Direct |
Source
Related
- Immunitybio, Inc.
- Selecky Christobel
- Immunitybio, Inc. shareholders
- Form 4 · Selecky Christobel · Jul 1, 2026
- Form 4 · Simon Barry J. · Oct 6, 2026
- Form 4 · Cohen Cheryl · Oct 6, 2026
- Schedule 13D/A · Cambridge Equities, LP · Aug 6, 2026
- Form 4 · Cohen Cheryl · Jul 6, 2026
- Form 4 · Simon Barry J. · Jun 26, 2026